Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) FCF Margin (2023 - 2025)

Cannabis Bioscience International Holdings' FCF Margin history spans 3 years, with the latest figure at 10.31% for Q4 2025.

  • For Q4 2025, FCF Margin rose 8678.0% year-over-year to 10.31%; the TTM value through Nov 2025 reached 264.09%, down 18582.0%, while the annual FY2025 figure was 108.78%, 8387.0% up from the prior year.
  • FCF Margin for Q4 2025 was 10.31% at Cannabis Bioscience International Holdings, up from 428.56% in the prior quarter.
  • Across five years, FCF Margin topped out at 10.31% in Q4 2025 and bottomed at 554.63% in Q1 2025.
  • The 3-year median for FCF Margin is 288.5% (2023), against an average of 251.84%.
  • The largest annual shift saw FCF Margin soared 36760bps in 2024 before it plummeted -52970bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 347.07% in 2023, then surged by 72bps to 97.09% in 2024, then skyrocketed by 89bps to 10.31% in 2025.
  • Per Business Quant, the three most recent readings for CBIH's FCF Margin are 10.31% (Q4 2025), 428.56% (Q3 2025), and 412.84% (Q2 2025).